Value-based analytics company Clarify Health announced it has raised $150 million in Series D funding.
The funding round brings its total valuation past $1 billion, a company spokesperson confirmed. With this round, Clarify is the latest digital health company to obtain 'unicorn status.' The Series D round was led by SoftBank Vision Fund 2, which was joined by BlackRock, Memorial Hermann Health System, Insight Partners, Spark Capital, KKR, Aspenwood Ventures, Rivas Capital and Sigmas Group. The company said the funds will be used to scale up its value-based payments platform.
It’s been a busy past 12 months for Clarify. In March, it acquired Embedded Healthcare, a behavioral change platform company, for an undisclosed price. Before that, Clarify bought Apervita’s value-optimization business to digitize historical and future contracts. Its previous round of funding was in June 2021, when it received a $115 million Series C funding round.
In an interview, CEO Dr. Jean Drouin said the company may be in the market for additional acquisitions or partnerships.
“There are a category of companies, which shall remain nameless, that have developed really interesting technology where you can essentially put an overlay on any EMR. The overlay can provide a pop-up that allows the doctor to easily document that certain [tasks] have been completed. We could either partner with or acquire a player in that space,” Drouin said.
